PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene - Pacific Biosciences (NASDAQ:PACB)
Summary by Benzinga
1 Articles
1 Articles
All
Left
Center
1
Right
PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene - Pacific Biosciences (NASDAQ:PACB)
MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution arrangement is designed to expand access to PacBio's HiFi long-read sequencing technology in clinical and research settings, with a focus on tr…
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage